Aprea Therapeutics (APRE) Misses Q4 EPS by 32c
Aprea Therapeutics (NASDAQ: APRE) reported Q4 EPS of ($0.32). Revenue for the quarter came in at $3.34 million.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.
Aprea Therapeutics (NASDAQ: APRE) reported Q4 EPS of ($0.32). Revenue for the quarter came in at $3.34 million.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.